Skip to content
Noricum

Company

About us

Noricum is a Spanish micro-enterprise founded in September 2004. It designs, develops, manufactures and markets the fusio® implant system and its prosthetic components, and produces recombinant human bone morphogenetic protein (rhBMP-2).

Eight people across two sites: implant and accessory production in Torrefarrera, Lleida; research, development and biomaterials production at the head office in San Sebastián de los Reyes, Madrid.

The implant does not compete on being different. It competes on being exact.
Noricum staff working in the metrology room, in lab coats and caps.

Metrology room — dimensional inspection of every batch

Mission

For more than 20 years, our mission has been to provide our customers with products that guarantee a high level of quality, safety and efficacy, and that enable them to carry out implant-prosthetic dental rehabilitation treatments on their patients in line with the highest standards of the state of the art.

We develop products of excellence for dental implantology using the latest technologies, supported by intensive R&D&I activity focused on two fundamental goals:

  • Improving the speed and quality of osseointegration of dental implants in the host bone.
  • Developing multifunctional biomaterial products for bone augmentation and regeneration.

Capabilities

Design, development, manufacture and marketing of sterile and non-sterile medical devices and dental sector materials.

  • C1Dental implants, their attachments and accessories.
  • C2Bone regeneration biomaterials.
  • C3Recombinant human bone morphogenetic protein type 2 (rhBMP-2).

Our history

  1. 2004

    • Noricum S.L. is founded with the mission of developing, manufacturing and marketing products of excellence for dental implantology.
    • Manufacturing of recombinant human bone morphogenetic protein (rhBMP-2) is established.
  2. 2008

    • The Spanish Agency of Medicines and Medical Devices (AEMPS) grants operating licence no. 5799-PS to Noricum's facilities.
  3. 2010

    • QMS certified to ISO 13485: certificate 9124.NRCM, IMQ.
    • First CE-marked products (CE 1363/MDD, IMQ): abutments and abutment caps, cylinders and prosthetic screws.
  4. 2011

    • Noricum starts marketing its products.
  5. 2012

    • CE marking for the first dental implant developed and manufactured at Noricum.
  6. 2015

    • CE marking of the noricum™ orthodontic micro-implant.
    • CE marking of the noricum™ trephine drill and thread former.
  1. 2017

    • CE marking of fusio® dental implants with SLA-P surface.
    • Development and validation of the Iso-bone bone regeneration material.
  2. 2020

    • CE marking of the noricum™ fixation tack and fixation screw.
    • CE marking of the fusio® bi-diameter (IP4) and transmucosal (IP5) dental implants.
    • CE marking of fusio® dental implants stored in saline.
  3. 2021

    • Development and validation of the Proteo-Graft bone regeneration material.
  4. 2022

    • Launch and sponsorship of the clinical investigation “Regeneration of Alveolar Sockets With rhBMP-2-loaded Bovine Bone Mineral (Proteo-Graft)” (NCT05717478).
  5. 2024

    • Start of the regulatory transition: MDD 93/42 → MDR 2017/745.
    • Confirmation letter received from notified body 0318.

What can be verified.

ISO 13485

Quality management system

Medical device manufacturing under ISO 13485 certification.

MADE IN SPAIN

In-house manufacturing

fusio® implants and noricum™ components and accessories are manufactured in Spain.

MARCADO CE

Alignment with regulatory requirements

CE MDD 93/42 → MDR 2017/745.

TRACEABILITY

Component control

Manufacturing control and component-level traceability across the system.

I+D

Bone regeneration

Manufacture of recombinant human bone morphogenetic protein 2 (rhBMP-2) and development of biomaterials for bone regeneration.

IN CLINIC

Clinical use

fusio® implants are used at the Brånemark Clinics in Lleida, Madrid and London.

Certifications

The document, not the seal.

ISO9124.NRCM

ISO 13485:2016

Quality management system

Issuing body
IMQ S.p.A. — CSQ, member of IQNet
Issued
28/04/2021
Valid until
02/07/2024

Design, development, manufacture and marketing of sterile and non-sterile medical devices and dental materials: dental implants, abutments and accessories, animal-origin bone matrix dental implant. Design, development, manufacture and marketing of recombinant proteins.

View the certificate →
CE1363/MDD

Directive 93/42/EEC — Annex II

Declaration of conformity of the QMS with MDD 93/42/EEC – Annex II

Issuing body
IMQ S.p.A.
Issued
17/12/2020
Valid until
26/05/2024

Dental prosthetic component, prosthetic fixing screw, transepithelial cylinder, healing screw, screw, cover screw, mini-conical cover screw, dental implants, micro-implants, dental burs, fixing pin and fixing mini-screw.

View the certificate →
MDRNOR101_DEX03_20240709v1

MDD 93/42/EEC → Regulation (EU) 2017/745

Confirmation letter from notified body 0318

Issuing body
CNCPS — Notified body 0318
Issued
10/07/2024
Status
MDR transition period

MDR application lodged and written agreement signed for: fusio® dental implant (class IIb) and noricum™ implant abutment (class IIb).

View the certificate →

Sites covered

  • Avenida de la Fuente Nueva 14, Nave 3A · 28703 San Sebastián de los Reyes, Madrid
  • C/ Pinyana 7, P.I. Les Comes · 25123 Torrefarrera, Lérida

Locations

Where it is manufactured and where the head office is.

Production · Lleida

Torrefarrera

Dental Implant and Accessory Production Department.

C/ Pinyana, 7 — Les Comes industrial estate
25123 Torrefarrera
Lleida, Spain

+34 973 22 56 20

Registered office

San Sebastián de los Reyes

Research, Development and Biomaterials Production Department.

Avenida Fuente Nueva, 14 — Nave 3A
28703 San Sebastián de los Reyes
Madrid, Spain

+34 916 639 816